Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$120.71 -0.5  -0.4%

Last Trade - 8:05pm

Sector
Healthcare
Size
Large Cap
Market Cap £12.46bn
Enterprise Value £15.30bn
Revenue £5.76bn
Position in Universe 537th / 6400

BRIEF-Quest Diagnostics - Adj EPS For Q2 Of 2020 Could Be In Range Of Breakeven To Slightly Profitable

Wed 3rd June, 2020 11:36am
June 3 (Reuters) - Quest Diagnostics Inc  DGX.N :
    * QUEST DIAGNOSTICS INC - BELIEVES THAT ITS ADJUSTED
EARNINGS PER
SHARE FOR Q2 OF 2020 COULD BE IN RANGE OF BREAKEVEN TO SLIGHTLY
PROFITABLE
    * QUEST DIAGNOSTICS - SINCE CO REPORTED RESULTS FOR Q1, HAS
CONTINUED TO EXPERIENCE MATERIAL DECLINE IN ITS TESTING VOLUMES
AS A RESULT OF PANDEMIC
    * QUEST DIAGNOSTICS- TESTING VOLUMES IN BASE BUSINESS
(EXCLUDING
COVID-19 MOLECULAR, ANTIBODY TESTING), HAVE RECOVERED FASTER
THAN ANTICIPATED ON APR 22

Source text: (https://bit.ly/2BtTT3u)
Further company coverage:  DGX.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.